Mesenchymal stem cells have been used for cardiovascular regenerative therapy for
decades. These cells have been established as one of the potential therapeutic agents …

Mesenchymal stem cells (MSCs) are self-renewing multipotent cells that have the capacity to
secrete multiple biologic factors that can restore and repair injured tissues. Preclinical and …

Cell therapy for disorders of the central nervous system has progressed to a new level of
clinical application. Various clinical studies are underway for Parkinson's disease, stroke …

Progestins are a broad class of progestational agents widely differing in their chemical
structures and pharmacological properties. Despite emerging data suggest that progestins …

Hematopoietic stem cells (HSC) represent the prototype stem cell within the body. Since
their discovery, HSC have been the focus of intensive research, and have proven invaluable …

There is currently no consensus among clinicians and scientists over the appropriate or
optimal timing for umbilical cord clamping. However, many clinical studies have suggested …

Traumatic brain injury (TBI), often called the signature wound of Iraq and Afghanistan wars,
is characterized by a progressive histopathology and long-lasting behavioral deficits …

Introduction: Stem cell therapy is an experimental treatment for brain disorders. Although a
cellular product, stem cells can be classified as biologics based on the cells' secretion of …

Among recently investigated stroke therapies, stem cell treatment holds great promise by
virtue of their putative ability to replace lost cells, promote endogenous neurogenesis, and …

Recent clinical trials using autologous bone marrow or peripheral blood cells to treat
myocardial infarction (MI) show controversial results, although the treatment has a good …